Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eliem Therapeutics Inc
(NQ:
ELYM
)
2.950
UNCHANGED
Streaming Delayed Price
Updated: 2:42 PM EDT, Jun 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.950
Bid (Size)
1.150 (3)
Ask (Size)
3.570 (1)
Prev. Close
2.950
Today's Range
2.950 - 2.950
52wk Range
2.210 - 5.200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
May 11, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
March 06, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Performance
YTD
-10.88%
-10.88%
1 Month
-12.46%
-12.46%
3 Month
-15.71%
-15.71%
6 Month
+17.53%
+17.53%
1 Year
-25.88%
-25.88%
More News
Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
February 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 20, 2023
Via
Benzinga
Eliem Pauses Development On Depression Drug, Lays Off 55% Workforce
February 10, 2023
Via
Benzinga
Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study
October 05, 2022
Via
Benzinga
Eliem Therapeutics: Q2 Earnings Insights
August 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
February 10, 2023
Via
Benzinga
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
February 09, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Shares Fall On Lower Back Pain Trial Setback
August 02, 2022
Via
Benzinga
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 04, 2023
Via
Benzinga
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
November 30, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
November 14, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
November 08, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Via
Benzinga
Eliem Therapeutics Provides Update on Pipeline Progress
October 05, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Eliem Therapeutics: Here's What You Need To Know
August 16, 2022
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 02, 2022
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Via
Benzinga
Eliem Announces Updated Development Plans For Its Delayed Depression Candidate
July 18, 2022
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
July 25, 2022
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Eliem Therapeutics: Here's What You Need To Know
July 11, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.